Patents by Inventor Samuel Nokuri

Samuel Nokuri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7160910
    Abstract: The provides compounds for the treatment of sickle-cell disease. In particular, the invention provides 5-membered heterocyclic anti-sickling agents that are highly effective and non-toxic, and methods for their use. The compounds include analogues and derivatives of naturally occurring occurring 5-hydroxymethyl-2-furfuraldehyde, 5-Ethyl-2-furfuraldehyde, 5-Methyl-2-furfuraldehyde, and 2-furfuraldehyde, and prodrug forms of the compound.
    Type: Grant
    Filed: December 3, 2003
    Date of Patent: January 9, 2007
    Assignee: Xechem International, Inc.
    Inventors: Martin K. Safo, Richmond Danso-Danquah, Samuel Nokuri, Faik N. Musayev, Gajanan S. Joshi, James C. Burnett, Donald J. Abraham
  • Publication number: 20040157801
    Abstract: The provides compounds for the treatment of sickle-cell disease. In particular, the invention provides 5-membered heterocyclic anti-sickling agents that are highly effective and non-toxic, and methods for their use. The compounds include analogues and derivatives of naturally occurring occurring 5-hydroxymethyl-2-furfuraldehyde, 5-Ethyl-2-furfuraldehyde, 5-Methyl-2-furfuraldehyde, and 2-furfuraldehyde, and prodrug forms of the compound.
    Type: Application
    Filed: December 3, 2003
    Publication date: August 12, 2004
    Inventors: Martin K. Safo, Richmond Danso-Danquah, Samuel Nokuri, Faik N. Musayev, Gajanan S. Joshi, James C. Burnett, Donald J. Abraham